menu search

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Weekly crypto market overview: xrp traders win big, binance begins a countdown, btc miners move $60m

Key Insights: Bitcoin price made a decent recovery following the US CPI data released on Thursday, but it appears the BTC ...

October 14, 2023, 12:55 pm

Bitcoin price analysis: here’s how btc could perform this weekend

Technical indicators provide insights into how the Bitcoin miners’ recent trading activity could impa...

October 13, 2023, 10:39 pm

mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023

Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...

October 13, 2023, 8:10 pm

Why hecla mining stock blasted higher today

The miner, which concentrates largely on precious metals, released an operational update. It detailed m...

October 13, 2023, 6:02 pm

Gold price recovery sends mining stocks surging

Great news for gold stocks today, as miners got a second wind thanks to a huge uptick in gold prices. W...

October 13, 2023, 5:59 pm

Buy gdx before it's too late

Gold miners have faced headwinds due to shifting interest rate expectations, impacting their performanc...

October 13, 2023, 2:52 pm

Gold forecast – prices bottomed and the march towards $2100 has begun

The final washout in metals and miners is over, and we may be in the beginning stages of a substantial ...

October 13, 2023, 2:12 pm

Newcrest mining investors strongly approve takeover by newmont

Newcrest Mining Limited (ASX:NCM), Australia's biggest gold miner, announced on Friday that its shareho...

October 13, 2023, 1:39 pm

Assessing bitcoin miners ahead of 2024 halving

Bitcoin is heading toward another halving in April 2024, an event that will bring with it significance for min...

October 13, 2023, 10:45 am

Sociedad quimica y minera de chile well positioned lithium stock

For a minute, people rushed into lithium at a pace that made the chemical seem more critical than water. What is the reason?...

October 13, 2023, 9:30 am

Bitcoin miners running up texans’ electricity bills, industry fighting new regulations

Bitcoin miners promised Texans that data centers consuming enormous amounts of energy to generate an im...

October 13, 2023, 9:14 am

Kimbell royalty partners looks attractive at current levels

Kimbell Royalty Partners is well positioned to increase its dividend in 2024 with its recent acquisition of mi...

October 12, 2023, 6:27 pm

Pegasus resources gets key permit to move ahead with maiden drill program at pine channel uranium project

Pegasus Resources Inc. (TSX-V:PEGA) has received the Pine Channel mineral Exploration Permit for Diamon...

October 12, 2023, 5:44 pm


Search within

Pages Search Results: